- Home
- DVLT vs HOWL Comparison
DVLT vs HOWL Comparison
Compare DVLT & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVLT
- HOWL
- Stock Information
- Founded
- DVLT 2010
- HOWL 2017
- Country
- DVLT United States
- HOWL United States
- Employees
- DVLT N/A
- HOWL N/A
- Industry
- DVLT
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- DVLT
- HOWL Health Care
- Exchange
- DVLT NYSE
- HOWL Nasdaq
- Market Cap
- DVLT 55.7M
- HOWL 53.8M
- IPO Year
- DVLT N/A
- HOWL 2021
- Fundamental
- Price
- DVLT $0.72
- HOWL $1.21
- Analyst Decision
- DVLT Strong Buy
- HOWL Strong Buy
- Analyst Count
- DVLT 1
- HOWL 3
- Target Price
- DVLT $3.00
- HOWL $8.33
- AVG Volume (30 Days)
- DVLT 445.5K
- HOWL 490.7K
- Earning Date
- DVLT 08-13-2025
- HOWL 08-07-2025
- Dividend Yield
- DVLT N/A
- HOWL N/A
- EPS Growth
- DVLT N/A
- HOWL N/A
- EPS
- DVLT N/A
- HOWL N/A
- Revenue
- DVLT $3,048,000.00
- HOWL $1,143,000.00
- Revenue This Year
- DVLT $434.03
- HOWL N/A
- Revenue Next Year
- DVLT $221.43
- HOWL N/A
- P/E Ratio
- DVLT N/A
- HOWL N/A
- Revenue Growth
- DVLT 63.08
- HOWL N/A
- 52 Week Low
- DVLT $0.60
- HOWL $0.60
- 52 Week High
- DVLT $3.34
- HOWL $4.18
- Technical
- Relative Strength Index (RSI)
- DVLT N/A
- HOWL 51.44
- Support Level
- DVLT N/A
- HOWL $1.19
- Resistance Level
- DVLT N/A
- HOWL $1.35
- Average True Range (ATR)
- DVLT 0.00
- HOWL 0.13
- MACD
- DVLT 0.00
- HOWL -0.02
- Stochastic Oscillator
- DVLT 0.00
- HOWL 21.84
About DVLT DATAVAULT AI INC
Datavault AI Inc is a data technology and licensing company that enables clients and strategic partners to monetize their Blockchain Data and AI Web 3.0 assets via tokenization, data ownership and digital twins offering two solutions: Data Science licenses High-Performance Computing (HPC) software applications and Web 3.0 data management serving the biotech, energy, education, fintech, real estate, and healthcare industries, among others. Acoustic Science licenses spatial and multichannel HD sound transmission, including proprietary brands ADIO, WiSA and Sumerian, to customers in sports & entertainment, events & venues, restaurants, automotive, finance, and other industries.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.